Unlocking the Potential of the HEART Pathway: Predicting MACE and Facilitating Nurse-Physician Collaboration in Chest Pain Unit
Zahra Behpour 1 2, Zahra Amirsardari 3 4, Haniye Aghakhani 5, Mohammadesmaeil Zanganehfar 1, Shiva Khaleghparast 5, Fidan Shabani 5, Hooman Bakhshandeh 1, Parham Sadeghipour 1
DOI: 10.1097/HPC.0000000000000374
|
 |
Developmental or Procedural Vena Cava Interruption and Venous Thromboembolism: A Review
Behnood Bikdeli 1 2 3 4, Parham Sadeghipour 5 6, Junyang Lou 1, Antoine Bejjani 1 2, Candrika D Khairani 1 2, Sina Rashedi 5, Robert Lookstein 7, Alexandra Lansky 8, Suresh Vedantham 9, Piotr Sobieszczyk 1, Carlos Mena-Hurtado 8, Ayaz Aghayev 10, Peter Henke 11, Ghazaleh Mehdipoor 4 12, Antonella Tufano 13, Saurav Chatterjee 14, Saskia Middeldorp 15, Suman Wasan 16, Riyaz Bashir 17, Irene M Lang 18, Mehdi H Shishehbor 19, Marie Gerhard-Herman 1, Jay Giri 20, Matthew T Menard 21, Sahil A Parikh 4 22, Lucia Mazzolai 23, Lisa Moores 24, Manuel Monreal 25, David Jimenez 26 27 28, Samuel Z Goldhaber 1 2, Harlan M Krumholz 3 8 29, Gregory Piazza 1 2
DOI: 10.1055/s-0043-1777991
|
|
Cost-Effectiveness Analysis of Pharmacogenomics-Guided Versus Standard Dosing of Warfarin in Patients with Mechanical Prosthetic Heart Valve
Homa Hemati 1, Marzieh Nosrati 2 1, Mandana Hasanzad 2 3, Parham Rahmani 1, Soroush Fariman 1 4, Mohadese Sarabi 1, Sepideh Shirvani 5, Parham Sadeghipour 5, Shekoufeh Nikfar 1
DOI: 10.5812/ijpr-143898 PMCID: PMC1130243
|
|
Rate of recurrence after discontinuing anticoagulation in patients with venous thromboembolism within 30 days after COVID-19 vaccine
Luis Jara-Palomares 1 2, Behnood Bikdeli 3 4 5 6, David Jiménez 2 7, Alfonso Muriel 8 9, Pablo Demelo-Rodríguez 10, Isabelle Mahé 11 12 13, Juan José López-Núñez 2 14 15 16, Joaquín Alfonso Megido 17, Begoña Fernández Jiménez 18, Manuel Monreal 2 19; RIETE Investigators
DOI: 10.1111/eci.14310
|
|
Pharmacokinetic and Pharmacodynamic Interactions between Food or Herbal Products and Oral Anticoagulants: Evidence Review, Practical Recommendations, and Knowledge Gaps
Azita H Talasaz 1 2 3, Bridget McGonagle 4 5, Mohsen HajiQasemi 6, Zahra A Ghelichkhan 7, Parham Sadeghipour 8, Sina Rashedi 4, Adam Cuker 9, Tara Lech 10, Samuel Z Goldhaber 4 5, Douglas L Jennings 1 2, Gregory Piazza 4 5, Behnood Bikdeli 4 5 11
DOI: 10.1055/s-0044-1790258
|
|
Empagliflozin to prevent post-operative atrial fibrillation in patients undergoing coronary artery bypass graft surgery: Rationale and design of the EMPOAF trial
Maryam Aghakouchakzadeh 1, Kaveh Hosseini 1 2, Majid Haghjoo 3, Parastoo Mirzabeigi 4, Masih Tajdini 1 2, Azita H Talasaz 1 5, Arash Jalali 2, Amir Askarinejad 6, Erfan Kohansal 6, Behnam Hedayat 1, Ehsan Parvas 1, Ali Bozorgi 1, Jamshid Bagheri 1, Nader Givtaj 7, Naser Hadavand 6, Alireza Hajighasemi 1, Seyed Hossein Ahmadi Tafti 1, Saeid Hosseini 7, Parham Sadeghipour 8, Hessam Kakavand 4 6
DOI: 10.1111/pace.15038
|
|
Ultraslow low-dose thrombolytic therapy in patients with acute mechanical prosthetic heart valve thrombosis - A prospective cohort study
Parham Sadeghipour 1, Masoume Salehi 2, Erfan Kohansal 3, Mohammadhossein Mozafarybazargany 3, Mozhgan Parsaee 4, Melody Farrashi 5, Sedigheh Saedi 3, Bahram Mohebbi 1, Nasim Naderi 3, Majid Maleki 5, Zahra Khajali 3, Raffaele De Caterina 6
DOI: 10.1016/j.ijcard.2024.132507
|
|
Comparative analysis of COVID-19-associated venous thromboembolism outcomes: evolution from 2020 to 2021-2022
Francisco Galeano-Valle 1 2, Pablo Demelo-Rodríguez 1 2, Rubén Alonso-Beato 3 4, José María Pedrajas 5, José Luis Fernández-Reyes 6, Romain Chopard 7, Parham Sadeghipour 8, Jana Hirmerova 9, Behnood Bikdeli 10 11 12, Manuel Monreal 13 14; RIETE Investigators
DOI: 10.1007/s11239-024-03026-6
|
|
Response to "Characteristics of the prothrombotic milieu in mitral stenosis patients managed with direct oral anticoagulants"
Parham Sadeghipour 1, Mohammadhossein Mozafarybazargany 2, Melody Farrashi 3, Raffaele De Caterina 4
DOI: 10.1016/j.ijcard.2024.132076
|
|
| |
| |
